Three Years Sustained Complete Remission Achieved in a Primary Refractory ALK-Positive Anaplastic T Large Cell Lymphoma Treated with Crizotinib

por Mahuad, Carolina Valeria, Repáraz, María de los Ángeles Vicente, Zerga, Marta E., Aizpurua, María Florencia, Casali, Claudia, Garate, Gonzalo
Publicado 2016